Activatory and inhibitory Fcγ receptors augment rituximab-mediated internalization of CD20 independent of signaling via the cytoplasmic domain
about
FcγR requirements leading to successful immunotherapy.IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions.Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB.Anti-FcγRIIB (CD32) Antibodies Differentially Modulate Murine FVIII-Specific Recall Response in vitro.Antitumour activity of the glycoengineered type II anti-CD20 antibody obinutuzumab (GA101) in combination with the MDM2-selective antagonist idasanutlin (RG7388).Association of Fcgamma receptor type 2A and 3A genotypes with rheumatoid arthritis in Chinese population.Rituximab effectively reverses Tyrosine kinase inhibitors (TKIs) resistance through inhibiting the accumulation of rictor on mitochondria-associated ER-membrane (MAM).Detection of Experimental and Clinical Immune Complexes by Measuring SHIP-1 Recruitment to the Inhibitory FcγRIIB.Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E
P2860
Q38615360-2E5B0425-C044-4DB6-9CCA-C247BB12DFC7Q38730371-6A110542-7C36-48C0-ABBE-2D4105A30606Q38752906-940BAE24-8F2B-436E-8414-EEB29D7BB7DEQ38754659-B8A4590B-113A-4398-A354-83A25091A14BQ38784989-6C7AE2E9-3BD7-4898-A0D4-82EF6A7A115CQ40368570-FCA2EABA-73B3-4801-B17E-3BD9E39907A8Q47746017-919061C7-F710-4E4E-847E-E444B55B75A7Q48204990-EA9CB7AF-DBA9-45A3-B02A-08C835B636FFQ58801878-B7BE4AD4-FAA9-4183-96A9-555FB4C2053E
P2860
Activatory and inhibitory Fcγ receptors augment rituximab-mediated internalization of CD20 independent of signaling via the cytoplasmic domain
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Activatory and inhibitory Fcγ ...... ing via the cytoplasmic domain
@ast
Activatory and inhibitory Fcγ ...... ing via the cytoplasmic domain
@en
type
label
Activatory and inhibitory Fcγ ...... ing via the cytoplasmic domain
@ast
Activatory and inhibitory Fcγ ...... ing via the cytoplasmic domain
@en
prefLabel
Activatory and inhibitory Fcγ ...... ing via the cytoplasmic domain
@ast
Activatory and inhibitory Fcγ ...... ing via the cytoplasmic domain
@en
P2093
P2860
P356
P1476
Activatory and inhibitory Fcγ ...... ing via the cytoplasmic domain
@en
P2093
Christian Klein
Claude H T Chan
Martin J Glennie
Stephen A Beers
P2860
P304
P356
10.1074/JBC.M114.593806
P407
P577
2015-01-07T00:00:00Z